By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile



111 West Lemon Avenue

Monrovia  California  91016  U.S.A.
Phone: 626-305-5900 Fax: 626-305-0350



Drug Discovery

Company News
Xencor Appoints Mark Lotz, R.Ph., As Vice President Of Regulatory Affairs And Wayne Saville, M.D., As Vice President Of Clinical Oncology 5/13/2015 6:37:54 AM
Xencor's XmAb5871 Program To Be Featured In Poster Presentation At European League Against Rheumatism (EULAR) 2015 Annual Meeting 5/11/2015 10:22:28 AM
Xencor Reports First Quarter 2015 Financial And Operating Results 5/4/2015 3:50:23 PM
Xencor To Webcast Presentations At Two Upcoming Conferences In May 4/29/2015 12:42:00 PM
Xencor To Host First Quarter 2015 Financial Results Webcast And Conference Call On May 4, 2015 4/28/2015 10:55:50 AM
Xencor Appoints A. Bruce Montgomery, M.D. To Board Of Directors 3/19/2015 6:54:19 AM
Xencor Announces Completion Of Public Offering Of Common Stock And Exercise In Full Of Option To Purchase Additional Shares Of Common Stock 3/3/2015 6:46:50 AM
Xencor Prices Public Offering Of Common Stock 2/25/2015 7:25:22 AM
Xencor Announces Proposed Public Offering Of Common Stock 2/24/2015 6:47:15 AM
Xencor Reports Fourth Quarter And Full Year 2014 Financial Results 2/20/2015 8:41:36 AM